← Eichor
Study identifier: NCT05343130 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of a Brain-Computer Interface Controlled Functional Electrical Stimulation Therapy for Spinal Cord Injury Neurorehabilitation

Condition: Cervical Spinal Cord Injury  ·  Sponsor: Instituto Nacional de Rehabilitacion

PhaseNA
Planned participants32
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study's main goal is to determine the efficacy of a therapy with brain-computer interface controlled functional electrical stimulation for neurorehabilitation of spinal cord injury patients' upper limbs. For this purpose, a randomized controlled trial will be performed to compare the clinical and physiological effects of the brain-computer interface therapy with those of a sham intervention comprised by the application of functional electrical stimulation independently of brain-computer interface control.

This description comes directly from the study's public registry record.

Talk to the study team

Jessica Cantillo-Negrete, PhD  ·  +525559991000  ·  jcantillo@inr.gob.mx

Ruben I Carino-Escobar, PhD  ·  +525559991000  ·  ricarino@inr.gob.mx

Always discuss trial participation with your own doctor first.

Locations (1)

Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra (National Institute of Rehabilitation)Tlalpan, Mexico City, MexicoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05343130